Patents by Inventor Eva Martin De La Nava

Eva Martin De La Nava has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070254869
    Abstract: Compounds of formula I wherein n, m, p, q, y, R1 R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating artherosclerosis and its sequelae.
    Type: Application
    Filed: October 7, 2004
    Publication date: November 1, 2007
    Applicant: ELI LILLY AND COMPANY
    Inventors: Guoqing Cao, Ana Escribano, Maria Fernandez, Todd Fields, Douglas Gernert, Christopher Cioffi, Robert Herr, Nathan Mantlo, Eva Martin De La Nava, Ana Mateo Herranz, Daniel Mayhugh, Xiaodong Wang
  • Publication number: 20070244095
    Abstract: Compounds of formula I wherein n, m, p, q, Y, R1 R2, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed.
    Type: Application
    Filed: June 23, 2005
    Publication date: October 18, 2007
    Inventors: Xinchao Chen, Christopher Cioffi, Sean Dinn, Ana Escribano, Maria Fernandez, Todd Fields, Robert Herr, Nathan Mantlo, Eva Martin De La Nava, Ana Mateo-Herranz, Saravanan Parthasarathy, Xiaodong Wang
  • Publication number: 20070208003
    Abstract: The present invention discloses compounds of formula I wherein A, n, m, j, q, y, W, X, Y, Z, R1, R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and its sequelae.
    Type: Application
    Filed: March 17, 2005
    Publication date: September 6, 2007
    Inventors: Michael Bell, Guoqing Cao, Ana Escribano, Maria Fernandez, Nathan Mantlo, Eva Martin de la Nava, Ana Mateo Herranz, Daniel Mayhugh, Xiadong Wang
  • Publication number: 20070173526
    Abstract: The present invention discloses compounds of formula (I) wherein A, n, q, K, W, X, Y; Z, R1, R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and its sequelae.
    Type: Application
    Filed: March 17, 2005
    Publication date: July 26, 2007
    Applicant: ELI LILLY AND COMPANY
    Inventors: Michael Bell, Guoqing Cao, Ana Escribano, Maria Fernandez, Peter Lander, Nathan Mantlo, Eva Martin de la Nava, Ana Mateo Herranz, Daniel Mayhugh, Xiaodong Wang
  • Publication number: 20060167268
    Abstract: This invention relates to novel compounds which are useful in the modulation of endogenous growth hormone levels in a mammal. The invention further relates to novel intermediates for use in the synthesis of said compounds, as well as novel processes employed in these syntheses. Also included are methods of treating a mammal which include the administration of said compounds.
    Type: Application
    Filed: March 31, 2003
    Publication date: July 27, 2006
    Applicant: Eli Lilly and Company, Patent Division,
    Inventors: Britta Evers, Ruehter Gerd, Eva Martin De La Nava, Mark Tebbe
  • Publication number: 20050240001
    Abstract: This invention relates to novel compounds which are useful in the modulation of endogenous growth hormone levels in a mammal. The invention further relates to novel intermediates for use in the synthesis of said compounds, as well as novel processes employed in these syntheses. Also included are methods of treating a mammal which include the administration of said compounds.
    Type: Application
    Filed: March 31, 2003
    Publication date: October 27, 2005
    Applicant: Eli Lilly and Company
    Inventors: Britta Evers, Ruehter Gerd, Eva Martin De La Nava, Mark Tebbe